• IP addresses are NOT logged in this forum so there's no point asking. Please note that this forum is full of homophobes, racists, lunatics, schizophrenics & absolute nut jobs with a smattering of geniuses, Chinese chauvinists, Moderate Muslims and last but not least a couple of "know-it-alls" constantly sprouting their dubious wisdom. If you believe that content generated by unsavory characters might cause you offense PLEASE LEAVE NOW! Sammyboy Admin and Staff are not responsible for your hurt feelings should you choose to read any of the content here.

    The OTHER forum is HERE so please stop asking.

How to avoid China's Sinovac vaccine?

“Right now, I would not take any Chinese vaccine, because there’s insufficient data,” said Bilahari Kausikan, an influential former official at Singapore’s Ministry of Foreign Affairs. He added that he would consider it only with “a proper report.”

China Wanted to Show Off Its Vaccines. It’s Backfiring.
Delays, inconsistent data, spotty disclosures and the country’s attacks on Western rivals have marred its ambitious effort to portray itself as a leader in global health.


00JPvirus-china-backlash1-print-articleLarge-v2.jpg

Brazilian indigenous people waiting in São Paulo to receive a coronavirus vaccine from the Chinese company Sinovac. Brazilian officials have complained that Chinese companies have been slow to ship the doses and ingredients.
Credit...Victor Moriyama for The New York Times
Sui-Lee Wee
By Sui-Lee Wee
  • Published Jan. 25, 2021Updated Jan. 29, 2021, 12:31 a.m. ET
China’s coronavirus vaccines were supposed to deliver a geopolitical win that showcased the country’s scientific prowess and generosity. Instead, in some places, they have set off a backlash.

Officials in Brazil and Turkey have complained that Chinese companies have been slow to ship the doses and ingredients. Disclosures about the Chinese vaccines have been slow and spotty. The few announcements that have trickled out suggest that China’s vaccines, while considered effective, cannot stop the virus as well as those developed by Pfizer and Moderna, the American drugmakers.

In the Philippines, some lawmakers have criticized the government’s decision to buy a vaccine made by a Chinese company, Sinovac. Officials in Malaysia and Singapore, which both ordered doses from Sinovac, have had to reassure their citizens that they would approve a vaccine only if it had been proved safe and effective.
“Right now, I would not take any Chinese vaccine, because there’s insufficient data,” said Bilahari Kausikan, an influential former official at Singapore’s Ministry of Foreign Affairs. He added that he would consider it only with “a proper report.”

At least 24 countries, most of them low and middle income, signed deals with the Chinese vaccine companies because they offered access when richer nations had claimed most of the doses made by Pfizer and Moderna. But the delays in getting the Chinese vaccines and the fact that the vaccines are less effective mean that those countries may take longer to vanquish the virus.


A Sinovac laboratory in Beijing. The world was caught off guard by the disclosure that the Sinovac vaccine may not be as effective as previously thought.

A Sinovac laboratory in Beijing. The world was caught off guard by the disclosure that the Sinovac vaccine may not be as effective as previously thought.
Credit...Thomas Peter/Reuters

Beijing officials who had hoped the vaccines would burnish China’s global reputation are now on the defensive. State media has started a misinformation campaign against the American vaccines, questioning the safety of the Pfizer and Moderna shots and promoting the Chinese vaccines as a better alternative. It has also distributed online videos that have been shared by the anti-vaccine movement in the United States.

Liu Xin, an anchor with CGTN, the state broadcaster, asked on Twitter why the foreign media had failed to “follow up” on the deaths of people in Germany who had taken one vaccine — though scientists have said the people were already seriously ill. Ms. Liu’s tweet was shared by Zhao Lijian, a top spokesman at China’s Foreign Ministry.

George Gao, the head of the Chinese Center for Disease Control and Prevention, has questioned the safety of the American vaccines because their developers used new techniques rather than the traditional method embraced by Chinese makers.

China had hoped its vaccines would prove it had become a scientific and diplomatic powerhouse. It remains on a par with the United States in the number of vaccines approved for emergency use or in late-stage trials. Sinopharm, a state-owned vaccine maker, and Sinovac have said they can produce up to a combined two billion doses this year, making them essential to the global fight against the coronavirus.

Unlike the Pfizer and Moderna vaccines, their doses can be kept at refrigerated temperatures and are more easily transported, making them appealing to the developing world. They have been doled out as aid to countries like Pakistan and the Philippines.

China’s campaign has been plagued with doubts, however. Many people have memories of the country’s vaccine scandals. Several governments remain angry about Beijing’s lack of openness about the virus in the early days of the pandemic. Its efforts at the start of last year to distribute masks and protective equipment to the West came under fire amid reports of shoddy quality and the demands by Chinese officials for public thanks.

A YouGov survey this month of roughly 19,000 people in 17 countries and regions showed that most were distrustful of a Covid-19 vaccine made in China. The misinformation campaign surrounding Western vaccines could further undermine its image.

The delays in shipments to places like Brazil and Turkey have been the latest hitch.

The first shipment of the Sinovac vaccine arrived in Turkey on Dec. 30.

The first shipment of the Sinovac vaccine arrived in Turkey on Dec. 30.
Credit...Aytug Can Sencar/European Pressphoto Agency, via Shutterstock

In Turkey, the government initially promised that 10 million doses of the Sinovac vaccine would arrive in December. Only three million did in early January, according to Fahrettin Koca, Turkey’s health minister. He did not explain the reason for the shortfall, which has been criticized by opposition politicians. The remaining doses finally arrived on Monday, according to Anadolu, Turkey’s state-run news agency.

In a statement, China’s Foreign Ministry cited its needs at home, where the coronavirus has re-emerged.

“Currently, China’s domestic vaccine demand is huge,” it said. “While meeting domestic demand, we are overcoming difficulties, thinking and trying ways to develop international vaccine cooperation with other countries, especially developing countries in different ways, and providing support and assistance according to their needs and within our capacity.”

The sporadic outbreaks could also hinder production. Sinovac, which declined to comment, said on Friday online that it was looking for workers for a Beijing-area facility where an outbreak had frightened off potential employees.

Countries like Turkey and Brazil are rolling out their immunization programs with a Sinovac vaccine because Western companies cannot deliver as quickly. But Brazil’s efforts have been delayed as well. Eduardo Pazuello, the country’s health minister, said China was not acting fast enough with the documents needed to export raw materials to Brazil.

“We are making strong moves at the diplomatic level to find where that resistance is and solve the problem,” Mr. Pazuello said at a news conference on Jan. 17.
On Wednesday, Rodrigo Maia, Brazil’s speaker of the house, told reporters that he had met the Chinese ambassador to Brazil, who “made it clear that there is no political obstacle, that it was a technical process that was delayed a little.”

Currently more than 150 million people — almost half the population — are eligible to be vaccinated. But each state makes the final decision about who goes first. The nation’s 21 million health care workers and three million residents of long-term care facilities were the first to qualify. In mid-January, federal officials urged all states to open up eligibility to everyone 65 and older and to adults of any age with medical conditions that put them at high risk of becoming seriously ill or dying from Covid-19. Adults in the general population are at the back of the line. If federal and state health officials can clear up bottlenecks in vaccine distribution, everyone 16 and older will become eligible as early as this spring or early summer. The vaccine hasn’t been approved in children, although studies are underway. It may be months before a vaccine is available for anyone under the age of 16. Go to your state health website for up-to-date information on vaccination policies in your area

Other vaccines are beginning to fill the gap. Brazil’s Health Ministry announced on Thursday that a previously delayed shipment of two million doses of the Oxford-AstraZeneca vaccine would arrive the next day from India.

A health worker in Indonesia delivering containers of the Sinovac vaccine. Officials there initially said the Sinovac vaccine had a 68 percent efficacy rate.

A health worker in Indonesia delivering containers of the Sinovac vaccine. Officials there initially said the Sinovac vaccine had a 68 percent efficacy rate.
Credit...Timur Matahari/Agence France-Presse — Getty Images

The world was also caught off guard by the disclosure that the Sinovac vaccine may not be as effective as previously thought. Earlier, officials in Turkey said trials there showed the vaccine had a 91 percent efficacy rate. In Indonesia, it was 68 percent. In Brazil, researchers initially said its efficacy was 78 percent.

Then, on Jan. 12, scientists said it had an efficacy rate of just over 50 percent, once people who experienced mild symptoms were included. That level is a hair above the threshold set by the World Health Organization to consider a vaccine effective. In a news conference last week, Sinovac’s chief executive officer, Yin Weidong, reiterated that the vaccine was 100 percent effective in preventing severe cases. He said the lower efficacy rate was a result of the trial’s focus on health care workers, who had a higher propensity of contracting Covid-19 than the general population.

Jair Bolsonaro, Brazil’s president and a critic of both China and its Covid-19 vaccines, pounced on the data. On Jan. 13, he mocked the vaccine’s efficacy rate, asking a supporter: “Is that 50 percent good?”

To be sure, the Chinese vaccines have a big appeal to many countries. More than 40 countries have expressed an interest in importing Chinese vaccines, according to China’s Foreign Ministry. Several world leaders, including President Recep Tayyip Erdogan of Turkey and President Joko Widodo of Indonesia, have gotten a Sinovac vaccine.

But the spotty and inconsistent disclosures about the vaccines remain a problem. Sinopharm has said a vaccine candidate made by its Beijing Institute of Biological Products arm has an efficacy rate of 79 percent, but it did not disclose crucial details. Sinopharm didn’t respond to a request for comment.

In Hong Kong, a special administrative region of China that has ordered 7.5 million doses of the Sinovac vaccine, officials have not received an application for emergency distribution nor any data from the Chinese company.

“Whether it is because they are not making enough or if they have no plans to send the vaccines to Hong Kong yet, I don’t know,” said Dr. Lau Chak Sing, who heads a Hong Kong government advisory panel on Covid-19 vaccines.

Data disclosure has also been an issue in the Philippines, which has secured 25 million Sinovac vaccine doses. Risa Hontiveros, an opposition lawmaker, said President Rodrigo Duterte’s administration “continues to cram their preference for Chinese-made vaccines down the public’s throat, without emergency use approval and with inconsistent data.”

Leila de Lima, a senator and opposition leader who is in prison, expressed anger that the government was paying $61 a dose, more than double what Sinovac’s partner in Indonesia is paying. The presidential palace said that that price was overstated but that it couldn’t divulge the real ones because of a confidentiality agreement.
Despite the uncertainty, many people may have little choice.

“I’ll have my jab,” said Kayihan Pala, a member of the Turkey Medical Association’s Covid-19 monitoring board. “I am waiting my turn, because there is no other option.”
Reporting was contributed by Letícia Casado, Tiffany May, Elsie Chen and Jason Gutierrez.
 
We have very few beds left. many patients are threatening to kill themselves. If you feel suicidal, please contact us.


Institute of Mental Health
10 Buangkok View, Buangkok Green, Medical Park, Singapore 539747
 
Oh look, now they're trying to cover their backside with this Mothershit infographic. Great timing too. :rolleyes:

By the way, I'm under 16, pregnant, have many severe allergies and have a severely compromised immune system. That means a freeing up a vaccine for someone who really wants it. :cool:

lol.png


This foolish vaccine gamble is going to backfire badly.
Predict your victims: politicians, pharmaceutical companies, healthcare systems, insurance companies. :whistling:
 
If want to avoid the ah tiong vaccine,,,than vaccinate now,,as the yank vaccine is the only game in town,,,for now
 
HK allows residents to choose vaccine due to concerns but not Singapore
by Correspondent
06/01/2021
in Current Affairs
Reading Time: 4min read
6

Source: CNA



In Parliament on Monday (4 Jan), Health Minister Gan Kim Yong told Singaporeans and long-term residents of Singapore that they will not be allowed to choose which type of COVID-19 vaccine to take, as this would “unnecessarily complicate the already complex vaccination programme”.
Sharing some details of the programme, Gan said people will need to make a booking before visiting vaccination centres for the COVID-19 shot, and will not get to choose the vaccine they want.
Following the first shipment of the Pfizer vaccine last month, more vaccines are expected to arrive here in the next few months, including those by US firm Moderna and China’s Sinovac, Gan said.
“Anyway, in the immediate term, only the Pfizer-BioNTech vaccine has been approved for use. So there is no choice,” he said, adding that Moderna’s and Sinovac’s vaccines are still being evaluated for safety and efficacy.
Singaporeans and long-term residents will be eligible for the free COVID-19 vaccination programme administered in Singapore.
At the same time, SCMP reported that Hong Kong, which has secured doses of the Pfizer, Sinovac and Oxford-AstraZeneca vaccines, does allow its residents to choose which vaccine they wanted to take. The announcement followed concerns that some residents would resist taking a vaccine manufactured by the Chinese firm, Sinovac.
In any case, Gan urged Singaporeans to get vaccinated, saying this would allow the economy to return to normality but stressed that the programme would be voluntary. In the past two weeks, Singapore has reported just 11 infections in the community compared to 264 that were imported.
Sinovac’s CEO bribes Chinese regulator to expedite its vaccine approvals
Meanwhile, it has been reported by Washington Post that Sinovac CEO had been caught bribing a top Chinese vaccine regulator for the past several years in order to help expedite the approvals of vaccines manufactured by his company (‘Sinovac CEO caught for bribing Chinese regulator remains unscathed and continues to oversee COVID-19 vaccine development‘).
sinovac-CEO-580x386.jpeg
Sinovac’s CEO Yin Weidong speaks to journalists during a tour of a vaccine factory in Beijing on 24 Sep 2020 (AP Photo).
Sinovac CEO Yin Weidong was not charged for bribing Yin Hongzhang, the former deputy director of the China Food and Drug Administration’s drug-testing center which oversees vaccine reviews. Yin Hongzhang, on the other hand, was sentenced in 2017 to a decade in prison for taking bribes. The 2 Yins are not related.

While Yin Hongzhang admitted to graft, Sinovac’s CEO said in his testimony that he “could not refuse” requests from a regulator. The Sinovac’s CEO was not charged and continues to oversee the company’s COVID-19 vaccine development.
Peter Humphrey, a British corporate investigator who has probed pharmaceutical corruption cases in China, called it “a bit extraordinary” that Sinovac emerged unscathed in 2017, despite its CEO confessing to bribing the Chinese regulator.
From past court records seen by The Post, Sinovac’s CEO admitted to giving more than US$83,000 in bribes from 2002 to 2011 to Yin Hongzhang and his wife. Yin Hongzhang himself had confessed to expediting vaccine certifications in return, for Sinovac’s hepatitis A, SARS, avian flu, foot-and-mouth disease and influenza A vaccines.
Sinovac’s fortune rose when it was handpicked by Beijing officials to lead development of vaccines for SARS, avian flu and swine flu starting from 2002.
Gleaning from court documents, The Post further revealed that not only Yin Hongzhang had admitted to taking bribes, at least 20 other Chinese officials and hospital administrators across five Chinese provinces had also admitted in court to taking bribes from Sinovac employees.
“In the vaccine industry, we usually give a commission to the person in charge to encourage them to use our vaccines,” one Sinovac’s salesperson said in a 2017 case in the southern province of Guangdong. The salesperson admitted to giving a hospital staff US$2,441 in kickbacks — “always through envelopes of cash” — as a reward for the hospital purchasing 5,351 doses of Sinovac’s hepatitis A vaccine from 2011 to 2015.
A number of details from the court cases have not been reported previously, in part because of China’s censored media, said The Post.
As of last month, Sinovac has not yet released efficacy data for its COVID-19 vaccine, making it unclear whether its vaccine can protect recipients as successfully as the vaccines from Moderna and Pfizer, which were more than 90 percent effective in preliminary analyses.
“The fact that the company has a history of bribery casts a long shadow of doubt over its unpublished, non-peer-reviewed data claims about its (COVID-19) vaccine,” said Arthur Caplan, medical ethics division director at New York University Langone Medical Center. “Even in a plague, a company with a morally dubious track record has to be treated with great caution concerning its claims.”
Vaccine mishaps continued to occur in China in recent years. Two years ago, another Chinese vaccine firm Sinopharm recalled 400,000 shots of diphtheria, pertussis and tetanus vaccine for substandard quality.
 
And now, the latest from the Gov dot sg propaganda department... :sneaky:

fBr8pTw.jpg
 
WTF is the government doing? Buy Sinovac's vaccine BEFORE it has been approved for use?
The government is misspending the citizens' reserves.

It is only a matter of time before Sinovac's vaccine is rubber-stamped "Approved for use".


Screenshot 2021-02-24 22.37.25.png

China's Sinovac vaccine arrives in Singapore, but is not yet approved for use
The Sinovac Covid-19 vaccine has not yet been authorised by the Health Sciences Authority for use in Singapore

The Sinovac Covid-19 vaccine has not yet been authorised by the Health Sciences Authority for use in Singapore
PHOTO: REUTERS
linette_lai.png

Linette Lai
Political Correspondent

24 FEB 2021

SINGAPORE - Singapore received its first shipment of China’s Sinovac vaccine on Tuesday (Feb 23) but has yet to authorise it for use, said the Health Ministry (MOH) on Wednesday (Feb 24).

It added that the vaccine maker has started submitting initial data to the Health Sciences Authority (HSA).

“HSA is currently awaiting Sinovac’s submission of all the necessary information in order to carry out a thorough scientific assessment of the manufacturing process, safety and efficacy of the vaccine under the Pandemic Special Access Route,” MOH said.

The Pfizer and Moderna vaccines currently in use here have received interim authorisation under this route.

As a condition of such authorisation, vaccine manufacturers have to monitor the longer-term efficacy of vaccines to determine the duration of protection against Covid-19.

They are also required to continue following up on the safety of their products for a longer period of time, in order to determine its full safety profile.

Both the Pfizer and Moderna vaccines involve injecting snippets of the virus’ genetic material into the body to stimulate an immune response.

In contrast, Sinovac's product is a more traditional inactivated vaccine, which makes use of killed virus particles. This method has been used in vaccines for diseases such as polio.

MOH also said it received a fresh shipment of the Pfizer vaccine on Wednesday, and will continue to monitor vaccine supplies closely.

In a Facebook post, the Chinese embassy said the delivery of the vaccine cements the agreement made by both countries to cooperate on issues related to the pandemic.

"China and Singapore have helped each other to meet the challenge since the Covid-19 epidemic broke out, setting a fine example for cooperation against the virus among countries," it wrote.

It added that China will continue to work with Singapore to "enhance cooperation on vaccine and epidemic control, build a global community of health for all, and win the final victory in the fight against the epidemic".
 
Last edited:
Will the approval for Sinovac vaccine be as rigorous as Pfizer's?

Large real world study confirms Pfizer Covid-19 vaccine 94% effective
A paramedic in Israel displays a vial of the Pfizer-BioNTech Covid-19 coronavirus vaccine.


A paramedic in Israel displays a vial of the Pfizer-BioNTech Covid-19 coronavirus vaccine.PHOTO: AFP

25 FEB 2021

WASHINGTON (AFP) - The Pfizer Covid-19 vaccine has proven 94 per cent effective in a study involving 1.2 million people in Israel, the first peer-reviewed real-world research confirming the power of mass immunisation campaigns to bring the pandemic to a close.

The paper, which was published in the New England Journal of Medicine on Wednesday (Feb 25), also demonstrated there is likely a strong protective benefit against infection, a crucial element in breaking onward transmission.

"The fact that the vaccines worked so well in the real world... really does suggest that if the nations of the world can find the will, we now have the means to end Covid-19 forever," said Ben Neuman, a virologist from Texas A&M University who was not involved in the research.

The experiment was carried out between Dec 20 2020 and Feb 1, 2021 - a period when a newer variant first identified in Britain was rampant in Israel, making the vaccine's performance all the more impressive.

Around 1.2 million people were divided into equal groups of vaccinated and unvaccinated.

Each vaccinated participant was matched to an unvaccinated "control" person of similar age, sex, geographic, medical and other characteristics.

Lead author Noam Barda, head of epidemiology and research at the Clalit Research Institute, told AFP the matching process was highly robust.

An elderly Ultra-Orthodox Jewish man from a particular neighbourhood with a particular set of comorbidities and flu vaccination history would be matched for another person fitting that precise profile, for example.

The researchers then recorded outcomes at days 14-20 after the first of the two doses and day seven or more after the second.

The efficacy against symptomatic infections was 57 per cent between 14-20 days after the first dose, but rose to 94 per cent seven days after the second dose - very close to the 95 per cent achieved during Phase 3 clinical trials.

People who received second doses were also highly protected against hospitalisation and death - though the precise numbers here are less significant and had a wider statistical range because of the relatively lower number of cases.

The study also found people who received their second dose had a 92 per cent lower chance of getting any form of infection at all compared to those who were unvaccinated.

While this finding was considered encouraging, the researchers and outside experts said it needs more confirming evidence.

That's because the participants weren't being systematically tested at regular intervals; rather, they were getting a test when they wanted one.

The authors attempted to correct for this with statistical methods but the result is still likely imperfect.

"Unless you are testing everyone all the time, this will miss some infections," said Natalie Dean, a biostatistician at the University of Florida.

She added she was certain there was a strong protective benefit, but "nailing down this number more precisely will require specialised study designs with frequent testing."
 
It added that the vaccine maker has started submitting initial data to the Health Sciences Authority (HSA).

“HSA is currently awaiting Sinovac’s submission of all the necessary information in order to carry out a thorough scientific assessment of the manufacturing process, safety and efficacy of the vaccine under the Pandemic Special Access Route,” MOH said.

The Pfizer and Moderna vaccines currently in use here have received interim authorisation under this route.
When Pfizer and Moderna causes injuries and death on the vaccine victims, and yet has authorisation under HSA. I can't trust HSA on validating the vaccines.
 
When Pfizer and Moderna causes injuries and death on the vaccine victims, and yet has authorisation under HSA. I can't trust HSA on validating the vaccines.

HSA was the same institution which had approved Slim 10, Choco Fit, and countless toxic TCM supplements from China.

Same for 'Registered with MOE', 'CASETrust', 'Lift inspection done by the BCA' etc.

You should be highly skeptical with those jiakliaobee bureaucrats. :cool:
 
Brain wash by chao angmoh again. Always say Western are the best, then bad mouthing Chinese and China is safer.

Vaccine is English shit who knows what it means by the word vaccine.

Chinese is antidote 消毒药. Angmoh say Chinese one is 70% good then be it.

Ur narrative is sway to Western value and u are a snake oil salesman for the West here... 卖花说花香 only.

Dickhead.
China communist is the best 中共土匪好太好了
 
HSA was the same institution which had approved Slim 10, Choco Fit, and countless toxic TCM supplements from China.

Same for 'Registered with MOE', 'CASETrust', 'Lift inspection done by the BCA' etc.

You should be highly skeptical with those jiakliaobee bureaucrats. :cool:
Pls never buy any products that are certified with haccp. They are all junks and poisonous. Haccp is a tool used by the Chinese communist to fool consumers
 
Pls never buy any products that are certified with haccp. They are all junks and poisonous. Haccp is a tool used by the Chinese communist to fool consumers

Sadly, many Tiong foods and snacks have this logo:

Qiyeshipin_Shengchanxuke_logo.JPG


Including some of the candies offered to the gods/Buddhas at the Waterloo Street temple. Some of them are rather tasty. :unsure::sick::eek::biggrin:
 
Back
Top